The global demand for Zidovudine Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020- 2026.
Zidovudine (ZDV), also well-known as azidothymidine (AZT), is an antiretroviral treatment used to prevent and treat HIV/ AIDS. It is generally mentioned for use with other antiretrovirals. AZT is usually medicated twice a day in combination with other antiretroviral therapies. This approach is raised to as Highly Active Antiretroviral Therapy (HAART) and is used to avoid the possibility of HIV resistance. Together they work to substantially reduce the risk of HIV infection following the first single exposure to the virus. It may be used to inhibit mother-to-child spread during birth or after a needlestick injury or other potential exposure. It can be used by oral or by slow injection into a vein. However, there are some side effects such as headaches, fever, and nausea.
Zidovudine is now a primary part of the medical use for both pre-exposure and post-exposure prophylaxis controlling the transmission of HIV from mother-to-child. This medicine throughout pregnancy, labor, and delivery and has been demonstrated to be important to uninfected siblings, prenatal and neonatal improvement, these factors are propelling the growth of the market. Without AZT, at least 12 to 17% of fetuses with HIV-infected mothers will become infected. This drug has been shown to decrease this risk to as little as 7%, when given in a three-part treatment including post-conception, delivery, and six weeks post-delivery that expected to create the good opportunity for zidovudine market in upcoming year. However, the cost for the treatment is likely to hamper the growth of the market. According to the guidelines of World Health Organization's List of Necessary Medicines, AZT is one of the safest and most operative medicines needed in a health system.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of zidovudine.
The entire zidovudine market has been sub-categorized into product and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- HIV Treatment
- HIV Prevention
This section covers regional segmentation which accentuates on current and future demand for zidovudine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Zidovudine Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the zidovudine market include Pharma Waldhof GmbH, Beike Biology Pharmacy. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.